Skip to content

VolitionRx Announces Pricing of $4.6 Million Public Offering

VolitionRx Limited has announced a public offering of 2,960,000 shares of common stock and warrants to purchase up to an aggregate of 1,480,000 shares at a price of $1.55 per share. The offering aims to raise $4.6 million, with potential additional proceeds of $2.3 million from warrant exercises. The offering is set to close on June 9, 2026, subject to customary closing conditions.

$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the full exercise of warrants HENDERSON, Nev., June 7, 2026 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announced…